When does Abbott (ABT.SW) report earnings?

Abbott (ABT.SW) announces earnings on **22 Jan 2026**. Expect results to cover revenue, margins, and forward guidance that can affect short-term trading of ABT.SW stock.

What is the current price and valuation for ABT.SW stock?

ABT.SW stock trades at **CHF100.00** intraday with a trailing **PE 15.70** and EPS **6.37**. These figures suggest a moderate valuation versus the Healthcare sector on SIX.

What price targets should investors consider for ABT.SW stock?

Scenario targets: conservative **CHF90.00**, base **CHF105.00**, bull **CHF115.00**. Use targets as reference points tied to earnings surprises and guidance shifts for ABT.SW stock.

How reliable are Meyka AI forecasts for ABT.SW stock?

Meyka AI's forecasts are model-based projections and not guarantees. They combine financials, trends, and sector data to estimate ABT.SW stock paths; always complement them with company filings and analyst notes.

CH Stocks

ABT.SW Abbott (SIX) CHF100.00 intraday: earnings 22 Jan 2026 could shift outlook

ByHuzaifa Zahoor January 21, 2026

ABT.SW stock trades at CHF100.00 intraday as investors position ahead of Abbott Laboratories’ earnings due 22 Jan 2026. The upcoming report will test diagnostics demand and device sales, two core drivers of Abbott’s Healthcare segment. Traders should note the stock’s PE 15.70 and EPS 6.37, which frame expectations for any guidance change. We review valuation, short-term technical cues, and how results could move the SIX-listed Abbott (Switzerland) listing.